Working at the MHRA A day in the life of a Pharmaceutical Assessor

Similar documents
HERBAL MEDICINES: Product Licence To Traditional Herbal Registration in the UK. Presented by: Mariam Aslam

Quality, Safety and Sourcing in Unlicensed Medicines

Response to Scottish Government A Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland December 2014

USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE

REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD

Clinical Trials in Third Countries

Use of unlicensed medicines and off-label uses

Name: Ben Cottam Job title: Policy and Communications Officer

The Committee for Medicinal Products for Human Use

Frequently asked questions

Information provided to Duchenne muscular dystrophy patient organisations regarding Raxone

Herbal medicines and supplements for cancer patients

The Danish Medicines Agency s availability strategy

The European Medicines Agency (EMA)

The Committee for Medicinal Products for Human Use

Eprosartan 300 mg, 400 mg and 600 mg Film-coated Tablets. (Eprosartan mesilate) PL 37222/

Facilitating adoption of off-patent, repurposed medicines into NHS clinical practice

A Guide to the Scottish Medicines Consortium

Guideline on influenza vaccines submission and procedural requirements

Summary of product characteristics (SmPC)

Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy

UPDATE ON THE GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

EMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS

Chief Dental Officer England: Advice on commercial practice of online registered dental practitioners selling patient group directions for NHS

Bioequivalence Requirements: USA and EU

Procedural advice on the submission of variations for annual update of human influenza inactivated vaccines applications in the centralised procedure

quality and safety of pharmacy preparations in Europe

Summary Public Assessment Report. Generics. Fluoxetina Aurobindo PT/H/1137/ /DC. Date:

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation

PHARMACEUTICAL SCIENCES (PHM SCI)

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES

Algorithms for Symptom Management. In End of Life Care

2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary

Ref: E 007. PGEU Response. Consultation on measures for improving the recognition of medical prescriptions issued in another Member State

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

Summary Public Assessment Report. Generics. Amiodarona Aurobindo. 200 mg, Tablets. (Amiodarone hydrochloride) PT/H/1444/001/DC

Blanka Hirschlerová. EDQM CEP conference Prague, Czech Republic

Case-by-Case Regulatory toxicology testing in Drug Development in Rare or Debilitating Disease

Using medicines beyond licence

Heng-Jung Lien 衛生福利部食品藥物管理署. Section Chief. Food and Drug Administration, Ministry of Health and Welfare

Other EU Activities Contributing to Harmonization of Labeling

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

Work plan for the joint CHMP/ CVMP Quality Working Party (QWP) for 2018

The English experience in a European regulatory context. E-cigarette summit Washington DC 1 st May 2018 Deborah Arnott Chief Executive ASH (UK)

Impact Summary: Therapeutic Products Bill Personal Import of Medicine by mail/courier

URGENT UPDATED ADVICE ON DOSAGE OF OSELTAMIVIR IN CHILDREN UNDER ONE YEAR OF AGE WITH SWINE FLU

How is the introduction of a new medicine regulated in the UK?

Regulation of Herbal and Traditional Medicines in Germany BfArM in Dialogue - TradReg 2017

Global Pediatric Development: We Are Making Progress. PMDA Perspective. Junko Sato, PhD PMDA

Ensuring the gap between science and practice is filled safely - MHRA

Update on Australian regulatory framework for medical devices

Standard Operating Procedures (SOP) Research and Development Office

Herbal Medicinal Products in Europe - Harmonisation Achieved?

Patient Group Directions Policy

Guideline scope Smoking cessation interventions and services

Draft Agreed by Pharmacokinetics Working Party February Adoption by CHMP for release for consultation 1 April 2016

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Job Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014

Decentralised Procedure. Public Assessment Report. Memantin AbZ 10 mg/20 mg Filmtabletten ; Starterpack

Regulatory Framework for Medical Devices in South Africa. 23 November 2018 Andrea Keyter Deputy Director: Medical Devices

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

How Clinical Trials Work

Update from FDA Office of Regulatory Affairs

Towards tailored and targeted asthma self-management using mobile technologies

Pandemic lessons learnt

Specific Challenges for Orphan Drugs with Paediatric Development

NEWSLETTER October The Pharmacovigilance Risk Assessment Committee July (PRAC) Meeting

Summary Public Assessment Report. Generics. Triflu Paracetamol, Ascorbic acid, Pheniramine maleate MT/H/0172/001/DC

Changing practice to support service delivery

The European Medicines Agency (EMA)

Regulatory update on guidelines relevant to paediatric formulations

Taking the guesswork out of supplying multi-compartment compliance aids: do pharmacists

Overview Consumer Health Products Law and Compliance Issues

SOP-QA-30 V Scope

Decentralised Procedure. Public Assessment Report. Nurofen Immedia 200mg Weichkapseln Ibuprofen DE/H/1482/001/DC

Workshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE

Prasugrel hydrochloride film-coated tablets 5 mg and 10 mg product-specific bioequivalence guidance

Volunteer - Supporter. Care team

Ensuring protection of public health and patients in member states: priorities, constraints, opportunities

Hearing aid dispenser approval process review Introduction Hearing aid dispenser data transfer... 6

Experience of paediatric formulations in Marketing Authorisatrion Applications

MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings

MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT. FERROFERON 200 mg/ml. Date:

Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE

MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

On the use of Amalgam for dental fillings in Sweden

Decision Making Across the Lifespan

AESGP views. Johannes Koch, Head of European Policy and International Affairs German Medicines Manufacturers' Association BAH. Who is AESGP?

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

Patient and Public Reference Group for Medicines ADTC Sub-group NHS Tayside 17 th February 2015

JOB DESCRIPTION JOB TITLE: STATUS: HOURS: SALARY: HOLIDAY: LOCATION: REPORTS TO: DIRECT REPORTS: KEY INTERNAL RELATIONSHIPS:

TCIs are only available on prescription and are usually started by a dermatology specialist.

Carolyn Savage Head of Communications and Events National Apprenticeship Service UVAC/ESFA HIGHER EDUCATION NEW APPRENTICESHIP PROVIDER EVENT

4. The School is committed to the prevention of substance misuse through education and support. PROCEDURE

Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended.

Transcription:

Working at the MHRA A day in the life of a Pharmaceutical Assessor. Seun Sogbesan, Associate Pharmaceutical Assessor 16 th April 2015

Presentation Aims To provide an insight into the day-to-day role of a pharmaceutical assessor To do some myth-busting To encourage you to consider working for the MHRA 2

The Agency s vision We protect and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research. 3

MHRA The Regulatory Body UK Regulatory Agency & Licensing Authority for medicines and medical devices Represents the UK on international bodies, which work to set consistent standards for medicines and medical devices world wide Involved in procedures for over 1000 new applications (both generics and new active substances) in 2014 4

To obtain a UK Marketing Authorisation The company prepares and submits a dossier (Common Technical Document) CTD describes the product from discovery through to commercialisation CTD consists of 5 modules module 1: Administration information module 2: Expert Overall Summaries module 3: Quality (Chemistry, Manufacturing and Controls) module 4: Toxicological/Preclinical module 5: Clinical dossiers are professionally assessed against QUALITY, SAFETY & EFFICACY increasingly, applications are being granted on a pan European basis [centralised procedure/decentralised procedure/mutual recognition procedure] 5

Pharmaceutical Assessors (PAs) Within Product Licensing, a large team of assessors work within the Clinical Trials unit, Biologicals unit, Parallel Imports unit and Product Life-cycle Assessment Teams Pharmaceutical/Quality assessors work as part of a multidisciplinary team alongside clinical, non-clinical and statistics and pharmacokinetics assessors (as required) Role: to assess the quality aspects of both initial and variation applications for marketing and take decisions on their suitability for approval 6

A day in the life Start by planning day s work around upcoming deadlines The rest of the day may be taken up with; assessing a new application for a product tablet, parenteral, inhaler, cream, patch assessing a proposed change to the licence presenting a challenging product/potential rejection to an Expert Committee e.g. CHM 7

A day in the life discussing an observation with colleagues in Inspectorate Providing scientific advice to an company Training sessions/cpd seminars Corresponding with applicants/european colleagues Flexibility and time management are key 8

Assessing the CMC section of an application A good oversight of Chemistry, Manufacturing and Controls (drug substance and product) is required. PAs also assess product information (SPC, PIL and labelling). Focus on breadth Credit for images: Shutterstock 9

Typical background of assessors (pharmaceutical) Pharmaceutical assessors are required to be EU registered pharmacists (exception for work in Biologicals) Typically an assessor might hold a PhD or have a good level of relevant experience e.g. manufacturing, R&D (chemical or pharmaceutical development), quality control, regulatory affairs Some assessors have a background in practice within hospital or community pharmacy 10

My career path up to now 11

The best thing about being an assessor 12

Key skills required Passion for science and quality medicines Attention to detail Analytical thinking Strong written and verbal communication skills Willingness to learn Ability to manage work and work flexibly to meet deadlines 13

Applying for pharmaceutical assessor roles Sign up to receive alerts for MHRA jobs, join the MHRA LinkedIn page Jobs are often advertised in the Pharmaceutical Journal, TOPRA website and LinkedIn Read more about the work of the Agency on the website e.g. work with ebola, e-cigarettes https://www.gov.uk/government/organisations/medi cines-and-healthcare-products-regulatory-agency Read up on drug regulation in the EU and the legal basis, dossier content, guidelines such as ICH Public assessment reports are published online 14

APS Regulatory Focus Group Available to APS members at no extra cost Can sign up online: My account -> Join focus group Real opportunity to contribute and shape this group COMING UP Regulatory Essentials: aimed at scientists fairly early in careers (Autumn 2015) For more information and to suggest topics; malcolm.dash@mhra.gsi.gov.uk or via APS 15

Additional Slides 16

MHRA - Overview Organisational structure 17